Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menaquinone 6 (MK-6) is a form of vitamin K2, a fat-soluble vitamin. It is a bacterial isoprenoid naphthoquinone that functions as an essential component of the electron transport chain in many microorganisms, cycling between its quinone and quinol forms to shuttle electrons and protons during anaerobic respiration. In humans, as a form of vitamin K2, it plays a crucial role as a coenzyme for vitamin K-dependent carboxylase, which is involved in the synthesis of proteins essential for blood coagulation, bone metabolism (e.g., osteocalcin, matrix Gla protein), and the inhibition of vascular calcification. It is available as a dietary supplement and is also being investigated for potential therapeutic uses, including in a clinical trial for comparing different dosages of Vitamin K2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Menaquinone 6.